Be a Smart Investor
Tuesday, January 9, 2018
Nevro Corp. (NVRO) Climbed After FDA Approval
Nevro Corp. (NVRO) announced Monday morning that it has received approval from the FDA for its Senza II Spinal Cord Stimulation System delivering HF10 therapy.
from RTT - Before the Bell http://ift.tt/2maqS1f
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment